# Tvardi Therapeutics (TVRD) — Earnings

TVRD · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/tvrd/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$1.00 |
| EPS estimate | −$0.68 |
| EPS surprise | −46.39% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 14, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1346830/000155837025011562/tvrd-20250630x10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 14, 2025 | −$0.68 | −$1.00 | -46.39% | — | — |
| Q1 2025 | May 13, 2025 | −$0.59 | −$3.22 | -450.43% | — | $2.6M |
| Q4 2024 | Mar 11, 2025 | −$7.08 | −$1.68 | 76.27% | $1.7M | — |
| Q1 2024 | May 13, 2024 | −$14.33 | −$20.16 | -40.70% | $1.7M | $2.1M |
| Q4 2023 | Mar 4, 2024 | −$16.06 | −$21.24 | -32.29% | $9.4M | $3.0M |
| Q3 2023 | Nov 13, 2023 | −$18.72 | −$18.72 | 0.00% | $10.0M | $4.9M |
| Q2 2023 | Aug 7, 2023 | −$19.38 | −$20.88 | -7.74% | $6.5M | $6.9M |
| Q1 2023 | May 15, 2023 | −$18.48 | −$17.64 | 4.55% | $4.9M | $6.2M |
| Q4 2022 | Mar 6, 2023 | −$12.34 | −$20.16 | -63.33% | $14.5M | $3.3M |
| Q3 2022 | Nov 7, 2022 | −$14.81 | −$15.48 | -4.51% | $8.8M | $10.8M |
| Q2 2022 | Aug 8, 2022 | −$9.41 | −$2.88 | 69.40% | $21.1M | $23.0M |
| Q1 2022 | May 9, 2022 | −$19.85 | −$18.72 | 5.70% | $2.6M | $4.8M |
| Q4 2021 | Mar 1, 2022 | −$18.41 | −$22.68 | -23.18% | $1.5M | $821,000.00 |
| Q3 2021 | Nov 8, 2021 | −$13.91 | −$0.72 | 94.82% | $15.6M | $20.3M |
| Q2 2021 | Aug 9, 2021 | −$19.74 | −$21.96 | -11.25% | $2.6M | — |
| Q1 2021 | May 10, 2021 | −$20.64 | −$16.92 | 18.02% | $3.0M | $1.9M |
| Q4 2020 | Feb 25, 2021 | $13.11 | $57.24 | 336.47% | $6.0M | $112.1M |
| Q3 2020 | Nov 9, 2020 | −$21.50 | −$12.60 | 41.39% | $4.7M | $9.3M |
| Q2 2020 | Aug 10, 2020 | −$23.97 | −$19.44 | 18.88% | $5.0M | $5.6M |
| Q1 2020 | May 11, 2020 | −$21.69 | −$22.32 | -2.90% | $4.7M | $8.1M |

## Frequently Asked Questions

### When did Tvardi Therapeutics (TVRD) last report earnings?

Tvardi Therapeutics last reported on Aug 14, 2025, covering fiscal Q2 2025.

### Did TVRD beat earnings estimates?

No. Tvardi Therapeutics reported EPS of −$1.00 for Q2 2025 against a −$0.68 estimate — a 46.39% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).